All Stories

  1. Understanding m/z range settings for MS/MS scans: a case study with intact glycopeptides
  2. Profiling glycoproteins enriched by surface-functionalized nanoparticles
  3. Sialoglycans on human T cells attenuate death programs executed through the Fas pathway
  4. Accelerating the stride toward functional glycoproteomics
  5. Improvements in Glycoproteomics through Architecture Changes to the Orbitrap Tribrid MS Platform
  6. Publisher Correction: irCLIP-RNP and Re-CLIP reveal patterns of dynamic protein assemblies on RNA
  7. Understanding m/z range settings for MS/MS scans: a case study with intact glycopeptides
  8. irCLIP-RNP and Re-CLIP reveal patterns of dynamic protein assemblies on RNA
  9. Extracting informative glycan-specific ions from glycopeptide MS/MS spectra with GlyCounter
  10. Revisiting the Effect of Trypsin Digestion Buffers on Artificial Deamidation
  11. Autonomous Dissociation-type Selection for Glycoproteomics Using a Real-Time Library Search
  12. Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer
  13. “Comparative Analysis of Glycoproteomic Software Using a Tailored Glycan Database”
  14. Instrumentation at the Leading Edge of Proteomics
  15. Instrumentation at the leading edge of proteomics
  16. Instrumentation at the leading edge of proteomics
  17. Microglia Mediate Contact-Independent Neuronal Network Remodeling via Secreted Neuraminidase-3 Associated with Extracellular Vesicles
  18. Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras
  19. Galectin-3 does not interact with RNA directly
  20. Microglia mediate contact-independent neuronal pruning via secreted Neuraminidase-3 associated with extracellular vesicles
  21. Design of a mucin-selective protease for targeted degradation of cancer-associated mucins
  22. Organism-wide, cell-type-specific secretome mapping of exercise training in mice
  23. The microenvironment dictates glycocalyx construction and immune surveillance
  24. Mutational screens highlight glycosylation as a modulator of colony-stimulating factor 3 receptor (CSF3R) activity
  25. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  26. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  27. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  28. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  29. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  30. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  31. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  32. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  33. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  34. Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  35. Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  36. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  37. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  38. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  39. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  40. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  41. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  42. Supplementary Data from Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  43. MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
  44. The 2022 Nobel Prize in Chemistry—sweet!
  45. Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
  46. Organism-wide secretome mapping uncovers pathways of tissue crosstalk in exercise
  47. Deciphering O-glycoprotease substrate preferences with O-Pair Search
  48. Antibody-lectin chimeras for glyco-immune checkpoint blockade
  49. The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection
  50. Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
  51. Deciphering O-glycoprotease substrate preferences with O-Pair Search
  52. Glycoproteomics
  53. Revealing the human mucinome
  54. Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
  55. Design of a mucin-selective protease for targeted degradation of cancer-associated mucins
  56. Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
  57. Deciphering O-glycoprotease substrate preferences with O-Pair Search
  58. Practical Effects of Intramolecular Hydrogen Rearrangement in Electron Transfer Dissociation-Based Proteomics
  59. Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4–pRB Axis in Fibroblasts at the Invasive Tumor Edge
  60. Protocol for cell type-specific labeling, enrichment, and proteomic profiling of plasma proteins in mice
  61. The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C
  62. LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
  63. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
  64. Revealing the human mucinome
  65. Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
  66. Modulation of immune cell reactivity with cis -binding Siglec agonists
  67. A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
  68. Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
  69. Cell type-selective secretome profiling in vivo
  70. Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
  71. O-Pair Search with MetaMorpheus for O-glycopeptide characterization
  72. Cell type-selective secretome profiling in vivo
  73. Optical Fiber-Enabled Photoactivation of Peptides and Proteins
  74. Lysosome Targeting Chimeras (LYTACs) That Engage a Liver-Specific Asialoglycoprotein Receptor for Targeted Protein Degradation
  75. Lysosome-targeting chimaeras for degradation of extracellular proteins
  76. Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
  77. Top-Down Characterization of an Intact Monoclonal Antibody Using Activated Ion Electron Transfer Dissociation
  78. Optimal Dissociation Methods Differ for N- and O-Glycopeptides
  79. Optimal Dissociation Methods Differ for N- and O-glycopeptides
  80. O-Pair Search with MetaMorpheus for O-glycopeptide Characterization
  81. Optimal Dissociation Methods Differ for N- and O-glycopeptides
  82. Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes
  83. Lysosome Targeting Chimeras (LYTACs) for the Degradation of Secreted and Membrane Proteins
  84. Broad and thematic remodeling of the surface glycoproteome on isogenic cells transformed with driving proliferative oncogenes
  85. Mutating stress-defense regulators in yeast improves biofuels engineering
  86. Interactive Peptide Spectral Annotator: A Versatile Web-Based Tool for Proteomic Applications
  87. Lysosome Targeting Chimeras (LYTACs) for the Degradation of Secreted and Membrane Proteins
  88. Lysosome Targeting Chimeras (LYTACs) for the Degradation of Secreted and Membrane Proteins
  89. Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis
  90. Rewired cellular signaling coordinates sugar and hypoxic responses for anaerobic xylose fermentation in yeast
  91. Top-Down Characterization of Proteins with Intact Disulfide Bonds Using Activated-Ion Electron Transfer Dissociation
  92. The Value of Activated Ion Electron Transfer Dissociation for High-Throughput Top-Down Characterization of Intact Proteins
  93. Improved Precursor Characterization for Data-Dependent Mass Spectrometry
  94. The Role of Electron Transfer Dissociation in Modern Proteomics
  95. Sequencing Larger Intact Proteins (30-70 kDa) with Activated Ion Electron Transfer Dissociation
  96. Activated Ion-Electron Transfer Dissociation Enables Comprehensive Top-Down Protein Fragmentation
  97. Negative Electron Transfer Dissociation Sequencing of Increasingly Sulfated Glycosaminoglycan Oligosaccharides on an Orbitrap Mass Spectrometer
  98. Implementation of Activated Ion Electron Transfer Dissociation on a Quadrupole-Orbitrap-Linear Ion Trap Hybrid Mass Spectrometer
  99. Phosphoproteomics with Activated Ion Electron Transfer Dissociation
  100. Sulfur Pentafluoride is a Preferred Reagent Cation for Negative Electron Transfer Dissociation
  101. Multi-omics Evidence for Inheritance of Energy Pathways in Red Blood Cells
  102. Full-Featured Search Algorithm for Negative Electron-Transfer Dissociation
  103. Genome Sequence and Analysis of a Stress-Tolerant, Wild-Derived Strain of Saccharomyces cerevisiae Used in Biofuels Research
  104. Proteomics Moves into the Fast Lane
  105. Mitochondrial protein hyperacetylation in the failing heart
  106. Enhanced Dissociation of Intact Proteins with High Capacity Electron Transfer Dissociation
  107. Phosphoproteomics in the Age of Rapid and Deep Proteome Profiling
  108. The Negative Mode Proteome with Activated Ion Negative Electron Transfer Dissociation (AI-NETD)
  109. A Calibration Routine for Efficient ETD in Large-Scale Proteomics
  110. Activated Ion Electron Transfer Dissociation for Improved Fragmentation of Intact Proteins
  111. Coupling Capillary Zone Electrophoresis with Electron Transfer Dissociation and Activated Ion Electron Transfer Dissociation for Top-Down Proteomics
  112. Neutron-Encoded Mass Signatures for Quantitative Top-Down Proteomics